feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

ChatGPT faces worldwide outages

trending

Alphabet dominates with Gemini 3

trending

OpenAI improves ChatGPT after Gemini

trending

Chennai schools closed due to rain

trending

Rupee collapses beyond 90/USD

trending

Avengers Doomsday trailer breaks tradition

trending

Rupee hits record low

trending

Canara Bank raises ₹3,500 crore

trending

JioHotstar releases Dies Irae

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / HIV Remission Achieved with Single-Copy Gene Mutation

HIV Remission Achieved with Single-Copy Gene Mutation

1 Dec

•

Summary

  • A German patient has been in HIV remission for six years.
  • Stem cell transplant used donor cells with one resistance gene copy.
  • This suggests alternative paths to potentially curing HIV.
HIV Remission Achieved with Single-Copy Gene Mutation

A German patient, referred to as Berlin 2 (B2), has maintained an HIV-free remission for an impressive six years after undergoing a stem cell transplant to treat leukemia. This marks him as the seventh individual known to achieve such long-term remission. Unlike previous cases where stem cell donors possessed two copies of the CCR5 Δ32 mutation conferring HIV resistance, B2 received cells with only a single copy. This finding challenges established theories on the mechanisms of HIV clearance and opens new avenues for research.

HIV's resilience stems from its ability to attack immune cells, mutate rapidly, and hide within dormant reservoirs. Antiretroviral therapy can suppress the virus, but latent reservoirs remain untouched. Stem cell transplants, by eradicating the patient's existing immune system and rebuilding it with donor cells, have proven effective in depleting these reservoirs. The graft-versus-reservoir response is crucial, where new immune cells target and eliminate remaining HIV hideouts.

While the CCR5 Δ32 stem cell procedure is not poised to become a standard HIV treatment due to its intensity and risks, the success in B2's case and other similar instances is invaluable. It shifts the focus from rare genetic mutations to understanding how to replicate reservoir reduction and graft-versus-reservoir responses through potentially less invasive means like pharmaceutical treatments and gene editing.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The Berlin 2 patient's six-year HIV remission, achieved with single-copy CCR5 resistance, suggests alternative pathways to cure HIV beyond requiring two copies of the resistance gene.
Stem cell transplants replace a patient's immune system with donor cells that can identify and eliminate hidden HIV reservoirs, a process known as graft-versus-reservoir response.
No, the intensive chemotherapy and full stem cell transplant are high-risk procedures not suitable for all HIV patients but inform future treatment strategies.

Read more news on

Healthside-arrow

You may also like

HIV Cure Hope: New Therapy Slows Virus Rebound

1 day ago • 50 reads

article image

HIV Meds: No More Explanations Needed

1 day ago • 10 reads

Aid Cuts Cripple HIV Fight in Poorest Nation

1 day ago • 10 reads

article image

HIV No Longer Death Sentence: Patient Urges Awareness

15 hours ago • 2 reads

article image

COVID Symptoms Evolve: What Doctors See Now

1 day ago • 6 reads

article image